Japanese researchers find that serum high-sensitivity C-reactive protein (hs-CRP), a non-specific marker of inflammation, is associated with the development of nephropathy in type 2 diabetes.
However, Yasuaki Hayashino, MD, of Tenri Hospital in Nara, Japa, found that hs-CRP is not directly responsible for the progression of nephropathy, a kidney disease that affects type 2 diabetics.
Studying hs-CRP
Hayashino and colleagues analysed longitudinal data of 2,518 patients with type 2 diabetes obtained from a national diabetes registry.
Their statistics showed a mean age of 66.1 years, body mass index (BMI) of 24.6 kg⁄m2 and HbA1c of 7.5 per cent (57.6 mmol/mol).
Depending on their serum hs-CRP levels, patients were divided into four groups. The researchers used Cox proportional hazards, a model to investigate several variables at a time, to assess serum baseline hs-CRP and its correlations with diabetic nephropathy at one year.
The researchers found that baseline serum hs-CRP levels were significantly associated with the urinary albumin-to-creatinine ratio, a factor used to detect diabetic nephropathy.
However, no significant associations were seen between hs-CRP levels and the risk of progression of nephropathy within type 2 diabetic patients.
The researchers concluded that further investigation was required, but that hs-CRP levels could possibly be used in the future to predict developing risks of the kidney complication.
The researchers wrote: “More research is needed to examine if there is an effective strategy to reduce the risk of diabetic nephropathy in a group of patients with diabetes and elevated levels of hs-CRP”.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…